178 related articles for article (PubMed ID: 36352434)
41. Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas.
Wilting SM; Steenbergen RD; Tijssen M; van Wieringen WN; Helmerhorst TJ; van Kemenade FJ; Bleeker MC; van de Wiel MA; Carvalho B; Meijer GA; Ylstra B; Meijer CJ; Snijders PJ
Cancer Res; 2009 Jan; 69(2):647-55. PubMed ID: 19147580
[TBL] [Abstract][Full Text] [Related]
42. Genome-wide DNA methylation profiling identifies two novel genes in cervical neoplasia.
El-Zein M; Cheishvili D; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Szyf M; Franco EL;
Int J Cancer; 2020 Sep; 147(5):1264-1274. PubMed ID: 31983058
[TBL] [Abstract][Full Text] [Related]
43. Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study.
Fujii T; Saito M; Hasegawa T; Iwata T; Kuramoto H; Kubushiro K; Ohmura M; Ochiai K; Arai H; Sakamoto M; Motoyama T; Aoki D
Int J Clin Oncol; 2015 Feb; 20(1):134-42. PubMed ID: 24744261
[TBL] [Abstract][Full Text] [Related]
44. Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer.
Heselmeyer-Haddad K; Sommerfeld K; White NM; Chaudhri N; Morrison LE; Palanisamy N; Wang ZY; Auer G; Steinberg W; Ried T
Am J Pathol; 2005 Apr; 166(4):1229-38. PubMed ID: 15793301
[TBL] [Abstract][Full Text] [Related]
45. Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy.
Lim EH; Ng SL; Li JL; Chang AR; Ng J; Ilancheran A; Low J; Quek SC; Tay EH
Gynecol Oncol; 2010 Nov; 119(2):225-31. PubMed ID: 20708786
[TBL] [Abstract][Full Text] [Related]
46. Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility study.
Salta S; Maia-Moço L; Estevão-Pereira H; Sequeira JP; Vieira R; Bartosch C; Petronilho S; Monteiro P; Sousa A; Baldaque I; Rodrigues J; Sousa H; Tavares F; Henrique R; Jerónimo C
Int J Cancer; 2021 Dec; 149(11):1916-1925. PubMed ID: 34460099
[TBL] [Abstract][Full Text] [Related]
47. Simultaneous detection of human papillomavirus integration and c-MYC gene amplification in cervical lesions: an emerging marker for the risk to progression.
Gimenes F; Souza RP; de Abreu AL; Pereira MW; Consolaro ME; da Silva VR
Arch Gynecol Obstet; 2016 Apr; 293(4):857-63. PubMed ID: 26315473
[TBL] [Abstract][Full Text] [Related]
48. APOBEC3G is increasingly expressed on the human uterine cervical intraepithelial neoplasia along with disease progression.
Iizuka T; Wakae K; Nakamura M; Kitamura K; Ono M; Fujiwara H; Muramatsu M
Am J Reprod Immunol; 2017 Oct; 78(4):. PubMed ID: 28590025
[TBL] [Abstract][Full Text] [Related]
49. Clinical significance of human telomerase RNA gene (hTERC) amplification in cervical squamous cell lesions detected by fluorescence in situ hybridization.
Jin Y; Li JP; He D; Tang LY; Zee CS; Guo SZ; Zhou J; Chen JN; Shao CK
Asian Pac J Cancer Prev; 2011; 12(5):1167-71. PubMed ID: 21875260
[TBL] [Abstract][Full Text] [Related]
50. Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome.
Alazawi W; Pett M; Strauss S; Moseley R; Gray J; Stanley M; Coleman N
Br J Cancer; 2004 Dec; 91(12):2063-70. PubMed ID: 15545968
[TBL] [Abstract][Full Text] [Related]
51. Human papillomavirus DNA, HPV L1 capsid protein and p16
Hu H; Zhao J; Yu W; Zhao J; Wang Z; Jin L; Yu Y; Han L; Wang L; Zhu H; Li F
Arch Gynecol Obstet; 2019 Jan; 299(1):141-149. PubMed ID: 30390110
[TBL] [Abstract][Full Text] [Related]
52. Long-term observational approach in women with histological diagnosis of cervical low-grade squamous intraepithelial lesion: an Italian multicentric retrospective cohort study.
Ciavattini A; Serri M; Di Giuseppe J; Liverani CA; Gardella B; Papiccio M; Delli Carpini G; Morini S; Clemente N; Sopracordevole F
BMJ Open; 2019 Jul; 9(7):e024920. PubMed ID: 31272971
[TBL] [Abstract][Full Text] [Related]
53. Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124-2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions.
Leeman A; Jenkins D; Del Pino M; Ordi J; Torné A; Doorbar J; Meijer CJLM; van Kemenade FJ; Quint WGV
Cancer Med; 2020 Apr; 9(7):2454-2461. PubMed ID: 32022461
[TBL] [Abstract][Full Text] [Related]
54. An evaluation of the diagnostic and prognostic significance of p16(INK4a) /p21(WAF1/Cip1) immunostaining in squamous intraepithelial lesions of the uterine cervix using liquid-based cytology specimens.
Ishida K; Araki A; Kobayashi M; Taniyama K; Nabika T; Nagasaki M
Diagn Cytopathol; 2014 Feb; 42(2):125-33. PubMed ID: 23754829
[TBL] [Abstract][Full Text] [Related]
55. Assessment of correlation between p16INK4a staining, specific subtype of human papillomavirus, and progression of LSIL/CIN1 lesions: first comparative study.
Razmpoosh M; Sansregret A; Oligny LL; Patey N; Dormoy-Raclet V; Ducruet T; Bouron-Dal Soglio D
Am J Clin Pathol; 2014 Jul; 142(1):104-10. PubMed ID: 24926093
[TBL] [Abstract][Full Text] [Related]
56. Diagnostic implications of L1, p16, and Ki-67 proteins and HPV DNA in low-grade cervical intraepithelial neoplasia.
Gatta LB; Berenzi A; Balzarini P; Dessy E; Angiero F; Alessandri G; Gambino A; Grigolato P; Benetti A
Int J Gynecol Pathol; 2011 Nov; 30(6):597-604. PubMed ID: 21979598
[TBL] [Abstract][Full Text] [Related]
57. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
[TBL] [Abstract][Full Text] [Related]
58. Identification of novel DNA methylation markers in cervical cancer.
Lai HC; Lin YW; Huang TH; Yan P; Huang RL; Wang HC; Liu J; Chan MW; Chu TY; Sun CA; Chang CC; Yu MH
Int J Cancer; 2008 Jul; 123(1):161-7. PubMed ID: 18398837
[TBL] [Abstract][Full Text] [Related]
59. Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions?
Lorenzato M; Caudroy S; Bronner C; Evrard G; Simon M; Durlach A; Birembaut P; Clavel C
Hum Pathol; 2005 Oct; 36(10):1101-7. PubMed ID: 16226110
[TBL] [Abstract][Full Text] [Related]
60. Galectin-9 expression links to malignant potential of cervical squamous cell carcinoma.
Liang M; Ueno M; Oomizu S; Arikawa T; Shinonaga R; Zhang S; Yamauchi A; Hirashima M
J Cancer Res Clin Oncol; 2008 Aug; 134(8):899-907. PubMed ID: 18264727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]